Cargando…
Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera
BACKGROUND: HIV-infected long-term non-progressor (LTNP) subjects can prevent viral replication and may harbor useful information for the development of both antibody and active vaccination treatments. In this study we used LTNP sera to examine the epitopes presented to the gp160 protein, and from t...
Autores principales: | Hao, Yuxia, Bai, Ge, Wang, Junping, Zhao, Longfeng, Sutherland, Kyle, Cai, Jianfeng, Cao, Chuanhai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410489/ https://www.ncbi.nlm.nih.gov/pubmed/25927639 http://dx.doi.org/10.1186/s12865-015-0094-z |
Ejemplares similares
-
Long term non-progressor (LTNP) HIV infection
por: Kumar, Praveen
Publicado: (2013) -
Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988–2010
por: Mandalia, Sundhiya, et al.
Publicado: (2012) -
HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India
por: Swathirajan, Chinnambedu Ravichandran, et al.
Publicado: (2018) -
Factors associated with conversion of long-term non-progressors to progressors: A prospective study of HIV perinatally infected paediatric survivors
por: Radhakrishna, Muttineni, et al.
Publicado: (2013) -
Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase
por: Eckstrand, C. D., et al.
Publicado: (2016)